ExLibris header image
SFX Logo
Title: Structural Insights into Selective Ligand–Receptor Interactions Leading to Receptor Inactivation Utilizing Selective Melanocortin 3 Receptor Antagonists
Source:

Biochemistry [0006-2960] Cai, Minying yr:2017


Collapse list of basic services Basic
Full text
Full text available via American Chemical Society Journals
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Leo, Chen H. "Serelaxin: A Novel Therapeutic for Vascular Diseases." Trends in pharmacological sciences 37.6 (2016): 498-507. Link to SFX for this item
2. Petrie, Emma J. "In a Class of Their Own – RXFP1 and RXFP2 are Unique Members of the LGR Family." Frontiers in Endocrinology 6 (2015): 137-137. Link to Full Text for this item Link to SFX for this item
3. Lange, P. "Chronic heart failure." Australian family physician 40.6 (2011): 362-362. Link to Full Text for this item Link to SFX for this item
4. Morrissey, Ryan P. "Chronic Heart Failure." American Journal of Cardiovascular Drugs 11.3 (2011): 153-171. Link to SFX for this item
5. Krum, H. "Medical therapy for chronic heart failure." Lancet 378.9792 (2011): 713-721. Link to SFX for this item
6. Hoffman, Timothy M. "Chronic Heart Failure." Pediatric critical care medicine 17.8 Suppl 1 (2016): 119-23. Link to SFX for this item
7. Burstrm, M. "Life experiences of security and insecurity among women with chronic heart failure." Journal of advanced nursing 68.4 (2011): 816-825. Link to Full Text for this item Link to SFX for this item
8. Mondoa, C. "Chronic heart failure." Practice nurse 30.5 (2005): 50-54. Link to SFX for this item
9. Huang, Z. "Activation of Relaxin Family Receptor 1 from Different Mammalian Species by Relaxin Peptide and Small-Molecule Agonist ML290." Frontiers in Endocrinology 6 (2015): 128-128. Link to Full Text for this item Link to SFX for this item
Select All Clear All

Expand list of advanced services Advanced